BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.42 -0.1  -1.4%

Last Trade - 16/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £249.4m
Enterprise Value £225.5m
Revenue £113.1m
Position in Universe 3973rd / 6850

BRIEF-Biodelivery Sciences Announces Phase I Clinical Trial Results At The American Academy Of Pain Medicine’S 36Th Annual Meeting

Thu 27th February, 2020 11:19pm
Feb 27 (Reuters) - BioDelivery Sciences International Inc
 BDSI.O :
    * BIODELIVERY SCIENCES ANNOUNCES PHASE I CLINICAL TRIAL
RESULTS AT
THE AMERICAN ACADEMY OF PAIN MEDICINE’S 36TH ANNUAL MEETING
    * BIODELIVERY SCIENCES - IMMEDIATE RELEASE ORAL OXYCODONE
HCL
ASSOCIATED WITH A DOSE-DEPENDENT DECREASE IN RESPIRATORY DRIVE
COMPARED TO PLACEBO

Source text for Eikon:  ID:nGNX7LPV0k 
Further company coverage:  BDSI.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.